tiprankstipranks
Trending News
More News >
Nektar Therapeutics (NKTR)
NASDAQ:NKTR
US Market

Nektar Therapeutics (NKTR) Income Statement

Compare
1,269 Followers

Nektar Therapeutics Income Statement

Last quarter (Q4 2024), Nektar Therapeutics's total revenue was $29.18M, an increase of 22.15% from the same quarter last year. In Q4, Nektar Therapeutics's net income was $7.26M. See Nektar Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 98.43M$ 90.12M$ 92.06M$ 101.91M$ 152.91M
Gross Profit
$ 67.74M$ 53.48M$ 70.42M$ 77.01M$ 133.44M
Operating Expenses
$ 172.94M$ 190.90M$ 310.66M$ 523.11M$ 513.36M
Depreciation and Amortization
$ 4.39M$ 7.82M$ 12.20M$ 13.00M$ 12.50M
EBITDA
$ -86.70M$ -243.11M$ -323.87M$ -462.97M$ -394.33M
Operating Income
$ -105.20M$ -137.43M$ -240.24M$ -446.10M$ -379.92M
Other Income/Expenses
$ -14.00M$ -138.83M$ -124.75M$ -77.18M$ -64.03M
Pretax Income
$ -119.20M$ -276.26M$ -364.98M$ -523.28M$ -443.95M
Net Income
$ -118.96M$ -276.06M$ -368.20M$ -523.84M$ -444.44M
Per Share Metrics
Basic EPS
$ -0.58$ -1.45$ -1.97$ -2.86$ -2.49
Diluted EPS
$ -0.58$ -1.45$ -1.97$ -2.86$ -2.49
Weighted Average Shares Outstanding
205.66M 190.00M 187.14M 183.30M 178.58M
Weighted Average Shares Outstanding (Diluted)
205.66M 190.00M 187.14M 183.30M 178.58M
Currency in USD

Nektar Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis